[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Daniel David Álamo Arce\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":44},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":27,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":5},"100594450","nesa-neuromodulation-versus-transcutaneous-posterior-tibial-stimulation-100594450",false,"NCT07019597","NESA Neuromodulation Versus Transcutaneous Posterior Tibial Stimulation","Non-invasive NESA Neuromodulation Versus Transcutaneous Posterior Tibial Nerve Stimulation for the Treatment of Overactive Bladder","NesaTibial","Inclusion Criteria:\n\n* Minimum criteria for a primary diagnosis of overactive bladder who have or have not received active\u002Falternative treatments for this pathology.\n* Patients with previous pharmacological treatments that have not obtained an adequate clinical response.\n* Patients whose cognitive abilities are competent to participate in the study and are able to complete the study questionnaires and have given written consent to participate in the study.\n* Without further contraindications for electrotherapy treatment such as serious use of pacemakers, pregnancy, internal bleeding, poor skin condition (ulcerations, wounds...) and\u002For phobia of electricity.\n\nExclusion Criteria:\n\n* Presence of urinary fistula.\n* Infections in the last 12 months.\n* Haematuria during the trial period.\n* Pregnancy or plans to become pregnant during the study.\n* Pathology of the central or peripheral nervous system (multiple sclerosis, Parkinson's disease, etc.).\n* Uncontrolled diabetes.\n* Currently treated with Botox injections for the bladder or within the last year.\n* Current treatment with interstim or currently implanted interstim device.\n* Bladder outlet obstruction.\n* Urinary retention.\n* Treatment with more than two antidepressants and\u002For multiple benzodiazepines, as well as antiepileptics.\n* Contraindications for electrotherapy treatment.","ALL",{"count":19,"type":20},25,"ESTIMATED","INTERVENTIONAL",[23],"NA","Introduction: Overactive bladder (OAB) is a common condition characterized by urinary urgency, frequency, and, in some cases, urge incontinence. Non-invasive neuromodulation has emerged as an effective therapeutic option by modulating the neural pathways involved in bladder control. This approach offers a promising alternative for patients who do not respond to conventional treatments.\n\nObjectives: To evaluate the effect of non-invasive NESA neuromodulation compared to posterior tibial stimulation in patients with overactive bladder.\n\ncompared to posterior tibial stimulation, with same-day exercises and patient education on quality of life, symptoms, discomfort and sleep.\n\nday of the session and patient education on quality of life, symptoms, discomfort and sleep.\n\nMethods: Twenty-four patients (24 women), aged 38-85 years with overactive bladder will be included in this experimental clinical trial study. Each patient will attend ten sessions two days a week. Patient life quality will be measured using SF-36, sleep quality with the Pittsburgh questionnaire, perception of urinari incontinence (UI) symptoms and patient quality of life with the ICIQ-SF questionnaire. All these variables will be measured before, immediately after the ten sessions and at two months after the end of treatment.\n\nEthic: The study was approved by the ethics committee of the University of Valencia, and all participants will be given an informed consent form.",[26],"Bladder Dysfunction",[28,29,30,31],"overactive bladder","Transcutaneous neuromodulation","Nesa Non-Invasive Neuromodulation","Posterior tibial nerve stimulation","RECRUITING","2025-06-10",{"date":35,"type":36},"2025-06-13","ACTUAL",{"date":38,"type":36},"2025-05-01",{"date":40,"type":20},"2025-09-01",{"name":42,"class":43},"Daniel David Álamo Arce","OTHER",""]